Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoronaVac Booster Dose Immunogenicity and Safety Study
NCT05150496Phase 2Suspended
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Dec 2022
- Primary completion
- Jan 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Biotech Ltd.. Started Dec 2022; status: suspended.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05150496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05150496.